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To determine the outbreak source of monkeypox virus 
(MPXV) infections in Unity State, Sudan, in November 2005, 
we conducted a retrospective investigation. MPXV was iden-
tiﬁ  ed in a sub-Sahelian savannah environment. Three case 
notiﬁ  cation categories were used: suspected, probable, and 
conﬁ  rmed. Molecular, virologic, and serologic assays were 
used to test blood specimens, vesicular swabs, and crust 
specimens obtained from symptomatic and recovering per-
sons. Ten laboratory-conﬁ  rmed cases and 9 probable cases 
of MPXV were reported during September–December 2005; 
no deaths occurred. Human-to-human transmission up to 5 
generations was described. Our investigation could not fully 
determine the source of the outbreak. Preliminary data indi-
cate that the MPXV strain isolated during this outbreak was 
a novel virus belonging to the Congo Basin clade. Our re-
sults indicate that MPXV should be considered endemic to 
the wetland areas of Unity State. This ﬁ  nding will enhance 
understanding of the ecologic niche for this virus. 
M
onkeypox virus (MPXV) is an orthopoxvirus and the 
causative agent for human monkeypox, a viral dis-
ease with clinical signs in humans similar to those seen in 
past smallpox patients (1,2). Human monkeypox is regular-
ly reported in remote villages of central Africa near tropical 
rainforests where persons may have contact with infected 
animals (3–7). In 2003, human monkeypox was identiﬁ  ed 
in the Western Hemisphere (8) after importation of rodents 
from Ghana.
In early November 2005, the medical team at the Mé-
decins Sans Frontières France (MSF-F) hospital in Bentiu, 
Unity State, Sudan, reported several suspected case-pa-
tients with generalized vesicopustular rash that resembled 
rash caused by MPXV. Biological samples were collected 
and sent to the World Health Organization (WHO) Col-
laborating Center for Smallpox and other Poxvirus Infec-
tions, Centers for Disease Control and Prevention (CDC), 
Atlanta, USA, where MPXV infection was conﬁ  rmed (9). 
Because human monkeypox had been reported in a dry 
savannah area in Africa, an investigation team conducted 
a retrospective analysis of the outbreak. A description of 
virologic studies indicating that MPXV isolated from the 
Sudan outbreak is a novel virus in the Congo Basin clade 
will be detailed in a subsequent report. Here, we report the 
results of a retrospective investigation that was conducted 
in January 2006.
Materials and Methods
Bentiu, capital of Unity State, is situated in southern 
Sudan ≈750 km southwest of Khartoum, on the southern 
banks of the Bahr al-Ghazal River (9°14′N, 29°50′E). 
Unity State is uniformly ﬂ  at with clay soil and its forests 
are scattered. During the dry season (November–April) its 
landscape exhibits characteristics of typical sub-Sahelian 
savannah; tall grass and inundated swamps predominate 
during the rainy season of May–October (10,11).
Unity State was affected greatly during the 21-year 
civil war in Sudan that largely destroyed the social fabric 
of its inhabitants (the Nuer), who were seminomadic per-
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sons (10). Massive displacement of the indigenous popu-
lation was reported in early 2000; returning refugees and 
displaced persons from Khartoum, Kenya, and Ethiopia 
occurred later in 2005. In November 2005, the underlying 
health infrastructure of Unity State, comprising a network 
of clinics and healthcare centers and a referral system, was 
still undergoing construction.
Initial Report of the Outbreak
On October 27, 2005, the MSF-F hospital team in Ben-
tiu examined an 8-month-old child who had a generalized 
vesiculopustular rash that was clinically consistent with 
an orthopoxvirus-associated disease. The child originated 
from the village of Nuria. He became ill on October 15, 
2005, with sudden onset of fever, cough, inﬂ  ammation of 
nasal mucous membranes, and enlarged cervical lymph 
nodes. On October, 16, 2005, a papular rash appeared on 
the infant’s head and within his mouth. Within 24 hours 
the rash had spread to cover ﬁ  rst his extremities and later 
his trunk; lesions were also seen on his palms and soles. 
On October, 29, 2005, a similar disease developed in the 
child’s mother with abrupt onset of fever and a papular 
rash, which developed pustular characteristics over the 
next 5 days. From October 27 through November 18, a pre-
liminary investigation by MSF-F hospital staff identiﬁ  ed an 
additional 18 similar cases in different villages. Crust and 
blood samples from the mother were sent to CDC in At-
lanta, where MPXV infection was conﬁ  rmed by PCR and 
virus isolation (9). Blood specimens, vesicular swabs, and 
crust specimens obtained from the 8-month-old child were 
sent to Institut Pasteur in Paris, where MPXV diagnosis 
was also conﬁ  rmed.
Epidemiologic Surveillance and Investigation of Cases
During January 15, 2006–January 30, 2006, an in-
vestigation team, comprising members of the Unity State 
Ministry of Health (MoH), Sudan Federal MoH, MSF-F, 
and WHO conducted a retrospective analysis of the MPXV 
outbreak in Bentiu to identify its source. Three case-no-
tiﬁ  cation categories were developed: suspected, probable, 
and conﬁ  rmed. A suspected case-patient was deﬁ  ned as 
any person from the outbreak zone who sought treatment 
during September 2005–January 2006 for fever (>37.5°C) 
and vesicular crusty rash. A probable case was deﬁ  ned as 
any person from the outbreak zone, evaluated by a clini-
cian, who sought treatment during September 2005–Janu-
ary 2006 for fever (>37.5°C), had a vesicular-pustular rash 
similar to that shown in a WHO reference photograph, and 
had an epidemiologic link to a conﬁ  rmed case. If labora-
tory samples were obtained during or after the illness, then 
the previous notiﬁ   cation categories were reclassiﬁ  ed  as 
laboratory-conﬁ  rmed cases or not a case. Results from a 
laboratory-conﬁ  rmed case were considered positive either 
by ELISA that showed immunoglobulin (Ig) M against or-
thopoxvirus, PCR ampliﬁ  cation of MPXV DNA, or MPXV 
isolation. Probable cases in which test results were positive 
by ELISA for IgG and negative for IgM were considered 
laboratory conﬁ  rmed if serum samples were collected >56 
days after onset of rash and the patient did not have a small-
pox vaccination scar or was too young to have been vacci-
nated against smallpox (7). Cases in which test results were 
negative by PCR and by ELISA for IgG and IgM were clas-
siﬁ  ed as not a case.
Suspected case-patients were identiﬁ  ed through analy-
sis of medical records from healthcare centers and through 
passive and active surveillance. Case-patients were pas-
sively identiﬁ  ed by staff at healthcare and hospital facili-
ties that served as sentinel surveillance sites. Active case 
ﬁ  nding was organized by the investigation team, who trav-
eled from village to village in areas where suspected cases 
had been reported. Epidemiologic and clinical information 
for each case-patient were collected by using data obtained 
from patient, family, and key informant interviews and 
from focal group discussions. Data were also obtained by 
comprehensive review of available patient medical ﬁ  les 
from the Bentiu MSF-F hospital and other local healthcare 
centers.
Data for each patient were compiled by using a stan-
dardized MPXV investigation form designed to collect 
information on the identity of the patient, clinical signs, 
treatment administered during course of disease, potential 
modes of infection, and laboratory ﬁ  ndings. Parameters es-
tablished by WHO for assessment of smallpox cases (12) 
were used to determine rash severity (i.e., benign, 5–25 le-
sions; moderate, 26–100 lesions; grave, 101–250 lesions; 
and extremely grave, >250 lesions). To obtain information 
on potential modes of infection, investigators sought to de-
termine the range of patient activities during the 2 weeks 
before illness onset, including visits to healthcare centers 
or traditional healers, attendance at funeral ceremonies, and 
any contacts that the patient may have had with other sus-
pected human case-patients or with wild animals.
Laboratory Analysis and Clinical Specimens
After informed consent was obtained, blood specimens 
were collected from acute-phase and recovering suspected 
or probable case-patients; vesicular swabs and crust speci-
mens were collected only from acute-phase case-patients. 
During October 2005–January 2006, samples (in some 
cases multiple samples from individual case-patients) were 
collected from 21 persons: 19 blood samples, 8 vesicu-
lar ﬂ  uid samples, and 7 crust samples. All samples were 
shipped for analysis to CDC in Atlanta or to Institut Pasteur 
in Paris.
Molecular, virologic, and serologic assays were used 
for diagnosis of MPXV. PCR-based molecular assays were 
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performed by using DNA prepared from lesions, swabs, 
smears, and EDTA–whole blood specimens; in some cases 
whole blood and dry blood preserved on ﬁ  lter paper were 
used if no other samples were available. Specimens posi-
tive by PCR for MPXV DNA were those that yielded posi-
tive results in >2 independent PCR tests (speciﬁ  c for dif-
ferent loci), including 1 that discriminates MPXV-speciﬁ  c 
DNA signatures from those of other orthopoxviruses. As-
says designed to detect generic-level and species-speciﬁ  c 
DNA signatures and virus culture procedures have been 
described (13). Lesion specimens that did not yield DNA 
signatures consistent with MPXV were subsequently ex-
amined for varicella virus (14).
Serologic testing alone was used to deﬁ  ne disease sta-
tus for suspected and probable case-patients who had no 
active lesions at the time of specimen collection. ELISAs 
were used for detection of orthopoxvirus-speciﬁ  c IgG or 
IgM from patient serum samples (15). Elevated levels of 
orthopoxvirus-reactive IgG in serum can indicate either 
MPXV infection or a previous smallpox vaccination (vac-
cinia virus) (7). Elevated IgM titer (7–56) after onset of 
rash in persons who had compatible clinical and epidemio-
logic characteristics was considered conﬁ  rmation of mon-
keypox.
Results
During September 20, 2005–January 31, 2006, a to-
tal of 49 cases meeting conﬁ  rmed, probable, or suspected 
status deﬁ  nitions were identiﬁ  ed in Unity State, Sudan 
(10 conﬁ  rmed, 9 probable, and 30 suspected). Among 
30 suspected case-patients reported by surveillance, 18 
could not be investigated because of logistic issues and 
12 were reclassiﬁ  ed as non–case-patients after investiga-
tion. Among the 12 non–case-patients, 2 who were 50 and 
40 years of age were positive for IgG that was attributed 
to remote vaccination. Other causes of vesicular rash were 
found among the 12 non–case-patients: cutaneous anthrax 
(1), fungus in HIV patients (2), Staphylococcus sp. (2), 
and chickenpox (5).
For epidemiologic analysis, a human monkeypox case 
was deﬁ  ned as any probable or conﬁ  rmed case identiﬁ  ed 
during the investigation. All 19 monkeypox case-patients 
were Nuers, and all recovered from illness (case-fatality 
rate [CFR] 0%).
Of the 10 laboratory-conﬁ  rmed case-patients, 3 were 
PCR positive, 3 were IgM and IgG positive, and 4 were 
IgG positive and were born after the cessation of the rou-
tine smallpox vaccination in 1975 (these 4 case-patients 
were 5, 11, 13, and 30 years of age, respectively). Tissue 
from 3 case-patients who were positive for MPXV DNA 
PCR yielded live virus. The hemagglutinin gene (942 bp) 
of Sudan viruses was identical to that of the MPXV Congo 
Basin strain MPXV2003_DRC and MPXV1979_Zaire and 
had 6 nt changes compared with that of MPXV West Africa 
strains MPXV2003_US and MPXV_WalterReed267. The 
full genome sequence comparative analysis is ongoing, but 
preliminary results show that the MPXV strain isolated 
during this outbreak has a novel genomic structural varia-
tion related to the Congo Basin MPXV clade. All 3 PCR-
positive case-patients were from the same village of Nuria; 
belonged to the same chain of transmission; and had blood 
specimens, vesicular swabs, and crust specimens obtained 
5–13 days after onset of symptoms. Samples were obtained 
from the 3 conﬁ  rmed case-patients who were IgM and IgG 
positive 25–70 days after onset of symptoms. From the 
4 conﬁ  rmed case-patients who were IgG positive, 2 had 
equivocal tests for IgM and samples were obtained 36 and 
39 days after onset of symptoms; 2 were negative for IgM 
and samples were obtained 50 and 78 days after onset of 
symptoms.
Of 9 probable case-patients, 2 case-patients agreed to 
the interview and clinical investigation but declined to pro-
vide clinical specimens. The 7 remaining probable case-
patients were not available for interviews during the Janu-
ary investigation.
The 19 monkeypox case-patients were reported from 
5 villages (Figure 1): 2 in Bentiu, 3 in Modin, 5 in Nuria, 
5 in Rubkona, and 4 in Wang Kay. All of these villages 
are located along the herbaceous wetlands along the Bahr-
el Ghazal River. The alleged index case-patient, identiﬁ  ed 
retrospectively, became ill on September 20, 2006, in Wang 
Kay village. The last cases were reported in Rubkona vil-
lage, with onset of laboratory-conﬁ  rmed illness occurring 
on December 15, 2005. The epidemic curve of the outbreak 
(Figure 2) has a monophasic distribution showing that the 
peak occurred during October 31, 2005–November 6, 2005. 
All case-patients were <32 years of age (range 8 months to 
32 years), and most (15/19, 79%) were <20 years of age. 
Ten (52%) of the 19 case-patients were women.
Description of Different Chains of Transmission
Epidemiologic evidence supported 4 different chains 
of transmission. Person-to-person transmission was docu-
mented in 3 chains. Fourteen case-patients reported contact 
with a suspected monkeypox case-patient before onset of 
symptoms; 1 case-patient was probably exposed to infected 
material during his hospitalization at the MSF-F hospital; 
and 6 case-patients did not report any known likely mode 
of infection. Among the 6 case-patients who did not report 
any known mode of infection, 3 case-patients reported that 
the rash began appearing around a preexisting wound (1 on 
the neck, 1 on the foot, and 1 on the arm), which could have 
been from the bite of an infected animal. None of the mon-
keypox case-patients reported contact with wild animals.
Figure 3 shows 3 transmission chains hypothesized to 
have occurred during the outbreak. The case-patient who 
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we believe may have initiated the transmission chain in 
Unity State was an 18-year-old man from Wang Kay vil-
lage. He was unavailable at the time of the investigation 
for follow-up, and his potential exposure to MPXV was 
not determined. Local authorities reported that no one was 
infected before him and that he had had a particularly se-
vere form of the disease; the recovery period lasted several 
weeks. He may have transmitted the virus to a traditional 
healer and tooth extractor (case-patient 2) who had treated 
him and who lived in the same village.
One independent focus of infection without secondary 
transmission was reported in Bentiu village (1 conﬁ  rmed 
case, IgG and IgM positive). This case-patient was a 19-
year-old woman who became ill on November 3 and was 
admitted to the MSF-F hospital on November 10 because 
of fever and generalized pustular lesions over her entire 
body. She could not be directly linked to the other chain 
of transmission, and her mode of infection could not be 
determined.
Clinical Characteristics of Case-Patients
Of the 19 case-patients, 8 were admitted to the MSF-F 
Bentiu hospital. The average interval between date of fever 
onset and date of hospital admission was 8.5 days (median 
8.5 days, minimum 4 days, maximum 14 days). The dis-
ease progression for 12 patients for whom information was 
available was similar: a febrile prodrome, cervical lymph-
adenopathy, throat and joint pain, and later skin eruptions. 
The median number of days from onset of fever to onset 
of rash was 4 days (range 1–6 days). Among the 19 case-
patients, the most commonly reported signs were fever 
(16 case-patients), lymphadenopathy (15 case-patients), 
and maculopapular rash (19 case-patients). Details of the 
frequency of individual symptoms among the monkeypox 
case-patients are reported in Figure 4.
Among 11 patients for whom we were able to obtain 
accurate information on number and location of lesions, 8 
had lesions distributed on the entire body and 3 had lesions 
on the face, arms, and legs. Among the 8 patients who had 
lesions on the entire body, we obtained information on the 
number of lesions for 6 of them (3 were moderate, 26–100 
lesions; 2 were grave, 101–250 lesions; and 1 extremely 
grave, >250 lesions). The average and median of case in-
tervals (i.e., the number of days between symptom onsets) 
was 14 and could be evaluated for 7 couples (case–second-
ary case).
Discussion
Smallpox transmission was interrupted in Sudan in 
1962, and smallpox did not return until after its reimpor-
tation during 1966–1968. The disease spread throughout 
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Figure 2. Date of symptom onset for 19 conﬁ  rmed and probable 
cases of human monkeypox virus infection in Unity State, Sudan, 
September 2005–December 2005. Onset date estimated for 5 
cases.
Figure 1. Geographic distribution of 
cases of human monkeypox virus 
infection in Unity State, Sudan, 2005. 
Inset shows location of Sudan (gray 
shading) and area of consideration 
within Unity State (white box).Human Monkeypox Outbreak, Sudan
the country, prompting the establishment of a surveillance 
and containment program that successfully stopped variola 
transmission; the last cases were reported in Sudan in De-
cember 1972. Mass vaccinations against smallpox contin-
ued until 1975, and an international commission certiﬁ  ed 
that Sudan was free of smallpox in November 1978 (12). 
After 33 years of epidemiologic silence, the events report-
ed here from 2005 represent the sole reported outbreak of 
an orthopoxvirus-associated disease in Sudan in the post-
smallpox era.
Despite difﬁ  culties during this investigation, we con-
ﬁ  rmed the presence of human monkeypox disease in Unity 
State, Sudan. Per our case deﬁ  nition, 10 conﬁ  rmed and 9 
probable cases were reported during September–December 
2005. Considering the high number of suspected cases that 
we were unable to investigate due to logistic constraints 
and some missing links in several potential transmission 
chains, we believe the scope of the outbreak is probably 
underestimated.
Characteristics of the epidemiologic curve are largely 
compatible with a point source of infection, reinforcing our 
hypothesis that the traditional healer and dentist (case-pa-
tient 2) may have spread the disease to different groups of 
patients. Young persons were possibly infected while being 
treated for childhood illnesses, and young adults may have 
been infected during ritual teeth extraction. No deaths oc-
curred, and evidence of human-to-human transmission for 
<5 generations was described. We found 4 chains of trans-
mission, 3 of which were associated with the activities of 
a traditional healer and tooth extractor. Clinical symptoms 
of case-patients in Sudan was similar to previous descrip-
tions in case-patients from central and West Africa. We 
found that 6 (75%) of 8 case-patients reported ulcers in the 
mouth, which is consistent with the frequency of oral le-
sions reported in unvaccinated patients in the Democratic 
Republic of the Congo, 1981–1986 (2).
In Sudan, as in much of sub-Saharan Africa, extract-
ing incisors (and sometimes canine milk teeth) occurs just 
after eruption of permanent dentition. This practice is as-
sociated with achieving adulthood, beauty, and tribal iden-
tity and is necessary for emitting speciﬁ  c linguistic sounds 
and consuming softer food textures (16,17). In addition, it 
is a common belief that canine milk teeth adversely affect 
the health of infants, causing diarrhea, vomiting, and fever. 
These teeth are often removed by a traditional healer when 
symptoms develop in the child. Because these practices are 
avenues for disease transmission, an educational campaign 
aimed at reducing the prevalence of this practice should 
be implemented. Culturally sensitive education could help 
implement change for safer practices and discourage this 
harmful ritual practice.
The low CFR observed during this outbreak could not 
be attributed to treatment, as most case-patients were ad-
mitted to the MSF-F hospital very late in the course of dis-
ease. Virulence differences between MPXV isolates from 
West Africa and the Congo Basin have been shown to be 
caused by genetic differences (18,19). The low CFR ob-
served in Sudan could be linked to the MPXV circulating in 
Unity State and its genetic difference with West Africa and 
Congo Basin isolates. In this regard, our preliminary results 
showed that the MPXV strain isolated during this outbreak 
is a novel virus. Alternatively, the low CFR could be re-
lated to the transmission of the virus or dose of the virus 
exposure, and the relatively older ages of affected persons.
This outbreak was reported in an area outside its tra-
ditional ecology (tropical rainforests), but rodents that had 
been incriminated in past human infections in other Afri-
can countries (e.g.,  Gambian rat [Cricetomys gambianus] 
or sun squirrels [Heliosciurius spp.]) are present in Unity 
State. This fact suggests that the virus may be endemic to 
this novel ecologic setting and could have been circulating 
undetected in nature for a long time. Nonetheless, we did 
not establish the source of animal-to-human exposure for 
MPXV.
Regarding the origin of this outbreak, one hypothesis is 
that the virus may be endemic to the wetland areas of Unity 
State. This hypothesis is supported by the discovery of a 
novel MPXV, the low CFR reported in monkeypox case-
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Figure 3. Pattern of virus transmission hypothesized to have 
occurred during outbreak of human monkeypox in Unity State, 
Sudan, 2005. Cases are arranged according to date of illness 
onset in the patient. Solid arrows indicate probable lines of person-
to-person transmission; dashed arrows depict undetermined 
transmission events (e.g., case-patient exposed to persons with 
monkeypox-like symptoms in same village where no formal link 
could be established). Numbers near arrows refer to the number 
of days between case onsets (case intervals); numbers with 
asterisks (case-patient 5a) refer to interval between possible date 
of exposure and symptom onset. Dashed boxes enclose case-
patients who were living in the same village. Case-patients 1x, 2v, 
2w, 2x, 3d, 4c, and 5a were hospitalized in the Médecins Sans 
Frontières France hospital in Bentiu, Unity State. Three additional 
cases were not related to these chains of transmission.RESEARCH
patients, and the identiﬁ  cation of several chains of trans-
mission that had no link between them, implying several 
introductions into the human population. The suggestion 
about monkeypox endemicity in Unity State is also sup-
ported by several descriptions from villagers; since 2001 
similar cases that may be consistent with monkeypox have 
been recorded in Unity State after severe ﬂ  ooding as was 
seen during the fall of 2005. Indeed, ﬂ  ooding in Unity Sate 
during August and September 2005 may have decreased 
the home range of terrestrial mammals and facilitated the 
possible contact between potential animal reservoirs and 
humans. However, several suspected monkeypox cases we 
investigated were later found to have alternative, laborato-
ry-conﬁ  rmed diagnoses, thus making anecdotal accounts of 
possible past human monkeypox outbreaks impossible to 
conﬁ  rm as orthopoxvirus infections.
An alternative hypothesis regarding the source of 
MPXV in Sudan is that the virus was introduced by im-
portation from a neighboring region endemic for MPXV, 
either by movement of infected animals or through human 
migration. Still, our investigation did not establish any di-
rect link to either the Democratic Republic of Congo or 
any of the countries in West Africa where monkeypox is 
endemic.
Additional investigation, notably ecologic studies, will 
be needed to demonstrate the endemicity of the virus in Su-
dan and to discover its natural reservoir host. These studies 
may have important consequences in the research of the 
ecologic niche of MPXV (20).
After the January 2006 investigation, the MoH in Uni-
ty State and MSF-F started a hospital-based surveillance 
system that enabled detection of 3 case-patients who had 
suspected pustular rash illnesses. Varicella virus infection 
was conﬁ  rmed for all. Unfortunately, surveillance was dis-
continued in April 2006 because of lack of resources; since 
then no suspected cases have been reported. To conﬁ  rm that 
monkeypox is endemic to Unity State and possibly all of 
southern Sudan, additional ecologic studies are needed, as 
well as long-term surveillance for rash and pustular disease, 
combined with laboratory conﬁ  rmation of suspected cases. 
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